A new gene therapy is giving people born deaf the chance to hear, often within just weeks. In a small but groundbreaking ...

Dead batteries could soon find a second lease on life thanks to a new chemical injection. One of the problems with lithium-ion batteries is that, over time, they slowly lose their charging efficacy, ...

A groundbreaking gene therapy trial has successfully restored hearing in individuals with a rare form of congenital deafness.

EXTON, Pa.--(BUSINESS WIRE)--Fibrocell Science, Inc. (OTC: FCSC) today announced that its Phase 2 study to evaluate the safety and efficacy of azficel-T (LAVIV®) for the treatment of patients with ...

Russell has a PhD in the history of medicine, violence, and colonialism. His research has explored topics including ethics, science governance, and medical involvement in violent contexts. Russell has ...